Chitosan Bionic Nerve Graft Structure for Strength and Biocompatibility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nerve grafts face challenges in achieving a balance between mechanical stability and biocompatibility, with natural materials being prone to breakage and synthetic materials having high toxicity, while current reconstruction methods fail to provide an optimal microenvironment for nerve regeneration.

Innovation Solution

A bionic nerve graft composed of a helical stent coated with a nanofiber membrane and filled with guide fibers and human bone marrow stromal cell-extracellular matrix (hBMSC-ECM), all made from chitosan, which provides mechanical support and biocompatibility, using mold pouring and electrostatic spinning techniques for production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If natural biological materials are used for nerve graft preparation, then biocompatibility and cell adhesion promotion are improved, but mechanical strength deteriorates causing breakage and collapse

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidmechanical strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent uses chitosan as a base material and applies crosslinking modification to create a composite structure that combines the biocompatibility of natural materials with enhanced mechanical strength through chemical crosslinking networks, resolving the contradiction between softness and strength

Inventive Principle:
Principle #40Composite materials

2Strength

If crosslinking agents or synthetic macromolecules are added to improve mechanical property, then mechanical strength is improved, but toxicity and biocompatibility deteriorate

Engineering Contradiction:
Improvemechanical strengthVSAvoidtoxicity
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The patent employs low-frequency ultrasonic treatment to change the physical parameters of the chitosan structure, creating porosity and improving mechanical properties without introducing toxic chemical crosslinking agents, thus avoiding the toxicity problem while maintaining strength enhancement

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If directional microstructure is constructed to induce directional nerve cell growth, then nerve regeneration guidance is improved, but microenvironment stability deteriorates

Engineering Contradiction:
Improvenerve regeneration guidanceVSAvoidmicroenvironment stability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent creates a segmented porous structure within the chitosan nerve graft that provides directional guidance for nerve cell growth while maintaining overall structural stability, allowing simultaneous achievement of guidance function and microenvironment stability

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The graft ensures sufficient mechanical support, promotes nerve regeneration, and maintains a conducive microenvironment with reduced immunogenicity and toxicity, achieving results comparable to autogenous nerve repair.

Implementation Method 1

with the progress of a micro-nano manufacturing technology such as electrospinning

Methodology Applied
Scientific EffectElectrostatic spinning: Electrostatic Deposition

Data Source

PatentUS20250241646A1Bionic nerve graft and preparation method thereof
Publication Date: 2025.07.31 NANTONG UNIV
  • US20250241646A1 patent drawing
  • US20250241646A1 patent drawing
  • US20250241646A1 patent drawing

AI summary

A bionic nerve graft and a preparation method thereof is provided. The bionic nerve graft includes a helical stent, a nanofiber membrane, guide fibers and hBMSC-ECM. A surface of the helical stent is coated with the nanofiber membrane, the guide fibers and the hBMSC-ECM are placed in a tube cavity of the helical stent, and the raw materials of the helical stent, the nanofiber membrane and the guide fibers are all chitosan. The preparation method includes the following steps: preparing the helical stent by a mold pouring method, coating the surface of the helical stent with the nanofiber membrane by an electrostatic spinning method, preparing the guide fibers by a template method, and filling the guide fibers and the hBMSC-ECM in the helical stent with the surface coated with the nanofiber membrane.